The Latest Breaking News from Moderna

Stock futures extend slide as Treasury yields leap; Moderna slumps after mixed data from flu vaccine trial; DraftKings jumps on narrower Q4 loss, solid revenue outlook; Deere earnings on deck with global equipment demand in focus and Applied Materials sees AI chip demand support firmer Q2 sales.

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

A Relative Strength Rating upgrade for Moderna shows improving technical performance. Will it continue?

After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…

Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.

“Patients need to advocate for themselves."

WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.